These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30342318)

  • 1. Ferulic acid reverses P-glycoprotein-mediated multidrug resistance via inhibition of PI3K/Akt/NF-κB signaling pathway.
    Muthusamy G; Gunaseelan S; Prasad NR
    J Nutr Biochem; 2019 Jan; 63():62-71. PubMed ID: 30342318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solasodine targets NF-κB signaling to overcome P-glycoprotein mediated multidrug resistance in cancer.
    Bharathiraja P; Balamurugan K; Govindasamy C; Prasad NR; Pore PM
    Exp Cell Res; 2024 Aug; 441(1):114153. PubMed ID: 39013486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway.
    Jiang L; Wang P; Sun YJ; Wu YJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):265. PubMed ID: 31215501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multiple-targets alkaloid nuciferine overcomes paclitaxel-induced drug resistance in vitro and in vivo.
    Liu RM; Xu P; Chen Q; Feng SL; Xie Y
    Phytomedicine; 2020 Dec; 79():153342. PubMed ID: 32992085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Polymersomes Co-Delivering Doxorubicin and Melittin to Overcome Multidrug Resistance.
    Han E; Kim D; Cho Y; Lee S; Kim J; Kim H
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor compound RY10-4 suppresses multidrug resistance in MCF-7/ADR cells by inhibiting PI3K/Akt/NF-κB signaling.
    Yang X; Ding Y; Xiao M; Liu X; Ruan J; Xue P
    Chem Biol Interact; 2017 Dec; 278():22-31. PubMed ID: 28987325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zuo Jin Wan reverses P-gp-mediated drug-resistance by inhibiting activation of the PI3K/Akt/NF-κB pathway.
    Sui H; Pan SF; Feng Y; Jin BH; Liu X; Zhou LH; Hou FG; Wang WH; Fu XL; Han ZF; Ren JL; Shi XL; Zhu HR; Li Q
    BMC Complement Altern Med; 2014 Aug; 14():279. PubMed ID: 25085593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
    Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
    Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-functional nano-system combining PI3K-110α/β inhibitor overcomes P-glycoprotein mediated MDR and improves anti-cancer efficiency.
    Lin R; Zhang L; Ye B; Wang Y; Li YD; Jason H; Liu W; Hu P; Chen J; Chen ZS; Chen Z
    Cancer Lett; 2023 Jun; 563():216181. PubMed ID: 37086953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma.
    Liu J; Zhu M; Feng Y; Tang Q; Xu M
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32400857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD133 and DNA-PK regulate MDR1 via the PI3K- or Akt-NF-κB pathway in multidrug-resistant glioblastoma cells in vitro.
    Xi G; Hayes E; Lewis R; Ichi S; Mania-Farnell B; Shim K; Takao T; Allender E; Mayanil CS; Tomita T
    Oncogene; 2016 Jan; 35(2):241-50. PubMed ID: 25823028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.
    Liu F; Liu S; He S; Xie Z; Zu X; Jiang Y
    Oncol Rep; 2010 May; 23(5):1469-75. PubMed ID: 20372866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway.
    Choi BH; Kim CG; Lim Y; Shin SY; Lee YH
    Cancer Lett; 2008 Jan; 259(1):111-8. PubMed ID: 18006147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEL-pep, an analog of melittin, disrupts cell membranes and reverses 5-fluorouracil resistance in human hepatocellular carcinoma cells.
    Ke M; Dong J; Wang Y; Zhang J; Zhang M; Wu Z; Lv Y; Wu R
    Int J Biochem Cell Biol; 2018 Aug; 101():39-48. PubMed ID: 29800725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ailanthone reverses multidrug resistance by inhibiting the P-glycoprotein-mediated efflux in resistant K562/A02 cells.
    Han F; Liu G; Sun C; Wei J
    Cell Mol Biol (Noisy-le-grand); 2018 Dec; 64(15):55-61. PubMed ID: 30672437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BI-2865, a pan-KRAS inhibitor, reverses the P-glycoprotein induced multidrug resistance in vitro and in vivo.
    Yang Q; To KKW; Hu G; Fu K; Yang C; Zhu S; Pan C; Wang F; Luo K; Fu L
    Cell Commun Signal; 2024 Jun; 22(1):325. PubMed ID: 38872211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low intensity ultrasound promotes the sensitivity of rat brain glioma to Doxorubicin by down-regulating the expressions of p-glucoprotein and multidrug resistance protein 1 in vitro and in vivo.
    Zhang Z; Xu K; Bi Y; Yu G; Wang S; Qi X; Zhong H
    PLoS One; 2013; 8(8):e70685. PubMed ID: 23940624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Icariin enhances cytotoxicity of doxorubicin in human multidrug-resistant osteosarcoma cells by inhibition of ABCB1 and down-regulation of the PI3K/Akt pathway.
    Wang Z; Yang L; Xia Y; Guo C; Kong L
    Biol Pharm Bull; 2015; 38(2):277-84. PubMed ID: 25747987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells.
    Zhang L; Li Y; Hu C; Chen Y; Chen Z; Chen ZS; Zhang JY; Fang S
    Mol Cancer; 2022 Apr; 21(1):103. PubMed ID: 35459184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
    Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
    Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.